论文部分内容阅读
目的:探讨冠心病患者口服救心丸后体内血浆内皮素含量的变化。方法:选取32例冠心病患者,随机分为常规组(n=16)和实验组(n=16),常规组采用常规西药治疗,实验组在常规治疗的基础上加用华佗救心丸,4周后,比较两组血浆内皮素含量变化。结果:实验组临床有效率为87.50%,明显高于常规组68.75%(p<0.05);治疗后两组血浆内皮素含量均较治疗前有所下降,且实验组下降幅度明显优于常规组(p<0.05)。结论:应用救心丸治疗冠心病疗效显著,可有效降低患者体内血浆内皮素含量,保护血管内皮损伤。
Objective: To investigate the change of plasma endothelin level in patients with coronary heart disease after oral administration of heart-saving pills. Methods: Thirty-two patients with coronary heart disease were randomly divided into routine group (n = 16) and experimental group (n = 16). The routine group was treated with routine western medicine. The experimental group was treated with Huatuo Jiuxin Wan, After 4 weeks, the changes of plasma endothelin levels were compared between the two groups. Results: The clinical effective rate in the experimental group was 87.50%, which was significantly higher than that in the conventional group (68.75%, p <0.05). The plasma endothelin levels in both groups decreased after treatment, and the decreasing rate in the experimental group was obviously better than that in the conventional group (p <0.05). Conclusion: The treatment of coronary heart disease with Qixin Pill has obvious curative effect, which can effectively reduce the content of plasma endothelin and protect the vascular endothelial injury.